Page last updated: 2024-08-23

alovudine and Pulmonary Arterial Remodeling

alovudine has been researched along with Pulmonary Arterial Remodeling in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashek, A; Boellaard, R; Bogaard, HJ; Botros, L; Cupitt, J; Dabral, S; de Man, FS; Dubois, O; Frings, V; Harms, HJ; Huisman, MC; Jansen, S; Lammertsma, AA; Pullamsetti, SS; Spruijt, OA; Vonk Noordegraaf, A; Wharton, J; Wilkins, MR; Zhao, L1

Other Studies

1 other study(ies) available for alovudine and Pulmonary Arterial Remodeling

ArticleYear
3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
    Circulation. Cardiovascular imaging, 2018, Volume: 11, Issue:8

    Topics: Adult; Aged; Animals; Case-Control Studies; Cell Proliferation; Cells, Cultured; Dideoxynucleosides; Disease Models, Animal; Equilibrative Nucleoside Transporter 1; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Humans; Ki-67 Antigen; Lung; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Predictive Value of Tests; Pulmonary Artery; Radiopharmaceuticals; Rats, Sprague-Dawley; Thymidine Kinase; Thymidine Phosphorylase; Vascular Remodeling

2018